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Summary: In vitro and in vivo parameters of flumazenil (FMZ) binding were measured in spiking and nonspiking neo cortex identified by intraoperative elcctrocorticography in epi leptic patients who underwent cortical resection for seizure control. In vitro measures of receptor atIinity (Ko), number (BmaJ and laminar distribution for r3HJ-FMZ binding in the epileptic focus (n = 38) were compared to nonspiking cortex from a subgroup of the patients (n = 12) and to tissue obtained from trauma patients (n = 5). The in vitro binding parameters were compared to in vivo ["ej-FMZ binding measured with positron emission tofuography (PET) (n = 19). The Bmax was higher in the 38 spiking tissues as compared to the 12 nonspik ing tissues (P = .012). Paired comparison of spiking versus nonspiking binding in the 12 patients from whom nonspiking tissue was available showed increases in both Ko (P = .037) and Bmax (P = .0047) in spiking cortex. A positive correlation Gamma-aminobutyric acid (GABA) is the major in hibitory neurotransmitter in the human brain, and its ac tion is mediated in part by the GABA A -benzodiazepine receptor (BDZ-R) complex. Positron emission tomogra phy (PET) studies using [ II C]-flumazenil (FMZ), a BDZ-R antagonist (Frey et aI., 1991) , have shown re duced BDZ-R binding in epileptic foci of patients with partial epilepsy (Savic et aI., 1988 (Savic et aI., , 1995 Henry et aI., 1993; Koepp et aI., 1996 Koepp et aI., , 1997 Szelies et aI., 1996) . In medial temporal lobe epilepsy, decreased hippocampal FMZ binding has been found consistently both in vivo was found between KD and Bmax values for 38 patients (r = 0.55, P < . 0001 ), the magnitude of the Ko increase being twice that of the Bmax increase. In addition, there was a significant correlation between the asymmetry indices of the in vivo FMZ binding on PET and in vitro KD of spiking cortex (n = 19, r = 0.52, P = .02). The laminar distribution of [3HJ-FMZ showed increased FMZ binding in cortical layers V-VI in spiking cor tex compared to nonspiking and control cortex. The increased receptor number in spiking cortical layers V-VI may be a com pensatory mechanism to decreased GABAergic input. The in creased Bmax in spiking cortex was accompanied by a larger decrease in the affinity of FMZ for the receptor suggesting that decreased FMZ binding in the epileptic focus measured with PET is due to a decrease in the atIinity of the tracer for the receptor. Key Words: Benzodiazepine receptor-Epilepsy sur gery-Flumazenil-Positron emission tomography.
with PET as well as in vitro (Koepp et aI., 1996 (Koepp et aI., , 1997 Johnson et aI., 1992; Olsen et aI., 1992; Burdette et aI., 1995; Hand et aI., 1997) . FMZ PET has proven also to be a sensitive method for visualizing neocortical epileptic foci (Savic et aI., 1995; Richardson et aI., 1996) . In vitro studies of BDZ-R in surgically resected human epileptic neocortex have revealed inconsistent findings (Sherwin et aI., 1986; Lloyd et aI., 1990; Olsen et aI., 1992; Bur dette et aI., 1995) . For example, Olsen et a1. (1992) , using eH]-FMZ quantitative autoradiography, found no significant difference in FMZ binding between epileptic neocortex and controls, whereas Burdette et a1. (1995) reported a significant increase of BDZ-R binding in layer V -VI of epileptic temporal neocortex. This latter finding is consistent with those from some animal models show ing increased GABA receptor density in epileptic cortex (Ross and Craig, 1981; Booker et aI., 1986; Craig and Colasanti, 1986) . However, Burdette et a1. (1995) did not include receptor affinity measurements in their analysis of human tissue. Such measures would be important be cause in vivo studies have shown that reduced FMZ bind-ing in the neocortex is not only able to localize epileptic foci, but the degree of binding asymmetries of homolo gous areas may be also a sensitive marker of the severity of epileptic dysfunction (Savic et aI., 1996) .
Previous in vitro BDZ-R binding studies reported the binding in homogenized cortex or in the entire thickness of the cortex, providing average values for cortical BDZ-R binding. However, BDZ-R binding shows a characteristic laminar distribution within the human cor tex (Zezu1a et aI., 1988) . Because some cortical layers can have a prominent role in the generation and propa gation of seizures (Connors, 1984; Telfeian and Connors, 1998) , a change in the laminar distribution of BZD-R could have an impact on epileptogenesis. Olsen et al. (1992) have reported a patient with altered laminar pat tern of the immunocytochemical distribution of GABA A receptors in the epileptic hippocampus, and suggested that synaptic rearrangement could have contributed to the epileptic circuitry. Mathern et al. (1997) have found increased staining of hippocampal GABAergic terminals and glutamic acid decarboxylase immunoreactivity (GAD; the synthesizing enzyme for GABA) in the kin dling model of limbic status epilepticus suggesting that synaptic reorganization of inhibitory (and excitatory) systems probably contributes to or generates chronic lim bic seizures. , No such findings of receptor redistribution have been reported yet for the human epileptic neocortex.
The present study reports in vitro and in vivo analyses of BDZ-R in epileptic neocortex of a large group of medically refractory epileptic patients (N = 38) in com parison to control subjects. In addition, in a subset of the epileptic group (N = 12), in vitro BZD-R density, af finity and laminar distribution were measured in the spiking and nons piking neocortical samples obtained from the same patient. Furthermore, we compared in vitro and in vivo parameters of cortical FMZ binding for patients in which both measures were available (N 19).
METHODS

Subjects
Patient group. Thirty-eight patients (22 males and 16 fe males; mean age, 11.9 years, SD ± 12.4; age range, I month to 47 years) who underwent neocortical resection for treatment of medically refractory epilepsy were subjects in this study. This study was performed in compliance with the Human Investi gation Committee at Wayne State University.
Control group. Control tissue samples were obtained from five men (mean age, 43.8 years; age range, 18 to 68 years) with traumatic brain injury who underwent cranial neurosurgery be cause of contusion (n = 4) or subdural hematoma (n = 1) 6 to 57 hours after the accident. None of them had seizures before or after the trauma and none of them was using medication before the accident. The resected brain tissue was carefully examined and only those samples that showed no macroscopic or microscopic abnormalities (e.g., signs of mechanical damage or hemorrhage) were used.
Intraoperative electrocorticography
All 38 epileptic patients underwent intraoperative electrocor ticography (ECoG) recording under general anesthesia (using nitrous oxide and isoflurane). The subdural electrode place ments were guided by scalp ictal EEG, magnetic resonance imaging, and 2-deoxy-2e sp]-fluoro-D-glucose (n = 38) as well as FMZ (n = 19) PET data. At least 10 minutes of ECoG recording was performed in each case. Use of anesthesia was decreased when background EEG activity was attenuated and/ or epileptiform activity was scanty. The position of the subdu ral electrodes, and the location of the active spiking and non spiking electrodes were recorded. When epileptiform activity was detected at the edges of the electrode plates, additional coverage was applied. The spiking area was defined as neocor tex showing at least 10 spikes/min during the ECoG. Nonspik ing areas were defined as cortical areas under the electrodes showing no epileptiform activity, separated by at least 2 cm from a spiking region.
In vitro FMZ binding studies
All tissue samples were obtained from the lobe containing the epileptic focus (26 temporal, 6 frontal, 4 parietal, 2 occipi tal), resected according to standard clinical criteria. In 12 of 38 patients, the resection contained nonspiking cortex (8 temporal, 2 occipital, I parietal. 1 frontal) in addition to spiking cortex, allowing the paired comparison of in vitro FMZ binding in these cases. Resected tissue was marked with clips immediately after the resection to identify the spiking tissue based on the recorded electrode positions and ECoG data. Tissue from the control subjects was prepared and studied using the same pro tocol as tissues from epilepsy surgery but no ECoG was per formed.
Tissue blocks were thawed to -16°C, and sections were cut at 20 [Lm in a Leica cryostat (Meyer Instruments, Inc., Houston, TX). Quantitative autoradiography of [3H]-PMZ was per formed essentially as described by Houser et al. (1988) . Tissue sections were preincubated for I hour at 4°C in assay buffer (0.17 mollL Tris-HCI, pH 7.4). Tissue was then incubated for I hour at 4°C in buffer containing eHJ-FMZ (New England Nuclear/Dupont, 70 Ci/mmol) at six different concentrations between 0.25 nmollL and 10 nmollL (three sections for each concentration). Nonspecific binding was measured in parallel assays containing I mmollL clonazepam. Slides were washed, dried, and apposed to tritium-sensitive film (Kodak BIOMAX MR, Eastman Kodak Co., Rochester, NY, U.S.A.) in radio graphic cassettes, together with tritium-embedded plastic stan dards (Amersham, Cleveland, OH, U.S.A.) calibrated against brain tissue containing varying concentrations of tritium for 2 to 4 weeks. Autoradiographic films were scanned with a Hew lett Packard ScanJet IICXIT (Palo Alto, CA, U.S.A.). Optical densities were measured for the standards and cortical regions of interest (ROI) using the ExplorerTest software package de veloped at the University of California at Los Angeles. The mean optical density of the values for at least three tissue sections for each ROI for each ligand concentration was ob tained and converted to fmol/mg tissue using the standard curve. ROIs were drawn to include all cortical layers, and Ko (receptor affinity; nmollL) and B max (receptor density; fmol/mg tissue) values were calculated. The binding parameters were determined by linear regression of the Scatchard plot. The slope of the fitted line is equal to affinity or -l/Ko, and the x intercept is equal to the B max ' In those 12 cases where spiking and nonspiking specimens were available, all steps of the in vitro binding protocol were performed in parallel for the sec tions from the same patient to minimize experimental variabil ity.
Cortical laminar distribution of BDZ-R density
Optical density histograms for 12 spiking and corresponding nonspiking cortical samples were displayed from the scanned autoradiographic films using the ExplorerTest software pack age. The "start" and "end" points of the histograms were indi cated on the surface on the cortex and the border of the grey and white matter (Fig. I) . For a better identification of these points, cortical slices from a high eHj-FMZ concentration (5 nmollL) were used. After calibration of the optical densities according to the standard curve, histograms showed the FMZ binding values (fmol/mg) from the left (surface) to the right (layer VI) across the entire cortex. To compare the histograms of the spiking and nons piking cortex from the same patient, the corresponding two curves were displayed in the same plot. Mean histograms for trauma control (n = 5), spiking (n = 12), and nons piking cortices (n = 12) were generated by calculat ing the mean value for each pixel in the histograms.
Histology
Cortical tissue blocks from the same location as tissue blocks used for the in vitro FMZ binding study were fixed in 10% buffered formalin for 24 to 48 hours. The sections were stained with hematoxilin and eosin, cresyl-violet, Luxol fast-blue, and glial fibrillary acidic protein antibody. The cortical layers were identified by light microscopy using cresyl-violet staining. Neuronal cell density in the cortex was graded by a modifica tion of the scale described by Watson et al. (l996) for hippo campus ( Table I) . (WM) were designated as the "start" (0 mm on the x scale) and "end" points C6 mm) of the histogram. Cresyl-violet staining of the tissue was used to identify the border between layers IV-V. The largest peak of FMZ binding is observed in layers III-IV, and a smaller peak is apparent between layers IV-V. 
In vivo FMZ binding studies
Nineteen of 38 patients (10 of 12 patients with both spiking and nonspiking tissue) had FMZ PET before the epilepsy sur gery. PET studies with the tracer FMZ were performed using the Siemens/Cn EXACTIHR whole body positron emission tomograph located at Children's Hospital of Michigan, Detroit. This scanner has a 15-cm field of view and generates 47 image planes with a slice thickness of 3.125 mm. The reconstructed image in-plane resolution obtained is 6.5 ± 0.35 mm at full width-at-half-maximum and 7.0 ± 0.53 mm in the axial direc tion (reconstruction parameters: Hanning filter with 0.20 cycles/pixel cutoff frequency). Attenuation correction was per formed on all images by applying the SIEMENS/Cn recon struction software using data from a 15-minute transmission scan of the head.
A complete drug history of all patients was obtained before the examination, and none of the patients received benzodiaz epines within 6 weeks before PET scan. A venous line was established for tracer injection. Children not able to remain still during the scanning phase were sedated with chloral hydrate (50 to 100 mg/kg by mouth) or nembutal (3 mg/kg intrave nously). Children who needed sedation were fasted for 4 hours before the PET procedure. Beginning at the time of injection, a 60-minute dynamic PET scan of the brain was performed (se quence: 4 x 30s, 3 x 60s, 2 x 150s, 2 x 300s, 4 x 600s). Summed images representing activity concentration between 10 and 20 minutes were used to display BDZ-R binding in the brain. Activity values were calculated for cortical ROI corre sponding to spiking and the contralateral homotopic region determined by ECoG (Fig. 2) . For the assessment of cortical asymmetries in FMZ binding, we calculated an asymmetry in dex (AI) as follows:
where CL is the radioactivity concentration (mCi/mL) for cor tical area contralateral to spiking area, and S is the spiking cortex activity concentration. These asymmetry indices were variance, and Pearson's correlation tests were used, where in dicated, using SPSS software (SPSS Inc. Chicago, IL, U.S.A.), P < .05 was considered as significant.
RESULTS
Histology
The histology findings of the 38 spiking cortical samples are detailed in Table I . Of 12 patients, in whom spiking and nonspiking cortices were obtained for com parison, none showed cell loss in the spiking cortex as compared to nonspiking cortex ( Table 2 ). The histology of these 12 paired neocortices was normal in four spiking and in seven nonspiking cortices, the abnormalities were restricted to the spiking cortex in three cases (two dys genesis, one tumor). In the other five patients both spik ing and nonspiking cortex was histologically abnormal (four dysgenesis, one white matter gliosis). Eleven of 12 patients had no neocortical magnetic resonance imaging abnormality. However, 7 of 12 pa tients had hippocampal atrophy on volumetric magnetic resonance imaging measurements, and 1 had tumor.
In vitro BDZ-R studies
The mean Bmax was significantly higher in the 38 spik ing tissue samples as compared to the 12 nonspiking samples (P = .012). However, the difference between the spiking and trauma control tissue did not reach sta tistical significance due to the small number of control specimens (n = 5; P = .06; Fig. 3A) significant differences were found in values of Ko be tween the spiking, nonspiking, and control tissues (P = .35; Fig. 3B ). However, the paired comparison of the spiking and nonspiking samples for 12 subjects, in whom both were available, showed significantly higher Bmax and Ko values in the spiking tissue (P = .0047 and P = .037, respectively).
Correlation between KD and Bmax values and clinical variables
A significant positive correlation was found between Ko and Bmax values of the spiking tissue (n = 38, r = 0.55; P < .0001) (Fig. 4A) . In other words, tissues with higher receptor number had lower affinity for FMZ. Fur thermore, the slope of the regression line (slope = 0.44) indicates that the Ko increases approximately twofold for a onefold increase in Bmax. There was no significant correlation between Ko and Bmax values of the nonspik ing tissue (n = 12, r = -0.139, P = .675).
A small positive correlation was found between the duration of epilepsy and the Ko values of the spiking cortex (n = 38, r = 0. 34; P = .034; not shown). No cor relation was found between the duration of epilepsy and Bmax, (r = 0.005 P = .97; not shown) as well as be tween the seizure frequency and Ko (r = -0.02; P .88) or Bmax (r = 0.15; P = .40) values.
Comparison of iii vivo versus in vitro FMZ binding data
Fifteen of 19 patients who had FMZ PET studies showed decreased binding by visual analysis in the re gion of the resected spiking tissue. A significant linear correlation was found between the AI of the in vivo FMZ binding and in vitro Ko of spiking cortex (r = 0.52, P = .02) (Fig. 4B) . No correlation was found between the AI of FMZ binding and the corresponding in vitro Bmax values of the spiking areas (r = 0.03; P = .89).
Laminar distribution of BDZ-R density in the human neocortex
The histograms for each of the five control cortices showed a similar laminar pattern of BDZ-R distribution which is shown in the averaged histogram for the group (Fig. SA) . The highest receptor density found in the first peak on the histogram was located in the pyramidal layer III and in the superficial part of layer IV as identified by cresyl-violet staining. The second peak on the histogram represented relatively high BDZ-R binding located in the cortical pyramidal layer V.
A similar laminar pattern of FMZ binding was found in all 12 nonspiking cortices as found on the averaged histogram (Fig. 5B) , although this curve appears to be smoother than the averaged histogram of the controls because of the higher number of cases used for averag ing. In contrast, the binding distribution of the spiking cortex was distinctly different from the distribution of corresponding nonspiking or control cortex in all 12 pa- decreased binding by visual analysis in the region of the resected spiking tissue, while four subjects showed no asymmetry consis tent with low measured asymmetry indices in these subjects.
tients. The averaged histogram of 12 spiking cortices showed a lower FMZ binding in layers I-IV and a higher binding in layers V-VI (Fig. 5B) . The receptor binding in layers V-VI was higher in the spiking tissue than in the nonspiking tissue in all individual cases. In addition, the laminar distribution of FMZ binding showed two different patterns in spiking cortex. In 6 of 12 patients, the FMZ binding histograms showed lower binding in the I-IV and higher in the V-VI cortical layers compared to nonspiking cortex (Fig. 5C ). In contrast, in the remaining 6 patients the distribution of receptor bind- Histograms of FMZ binding for spiking (continuous line) and nonspiking (dotted line) cortex from one patient. In this patient the FMZ binding is higher in all layers in the spiking cortex, although the shape of both histograms are similar to the control group. This pattern was seen in the remaining six patients.
ing showed the same pattern found in the nons piking and control cortices (Fig. SD) . However, the histograms of spiking cortices were shifted upwards compared to non spiking cortex, indicating higher receptor binding in all layers. Moreover, there was no relationship between the pattern of laminar distribution and histologic findings. In both groups, histology showed pathologic changes in four subjects and was normal in two.
DISCUSSION
Methodological considerations
In this study we accepted ECoG as the gold standard to study the relationship between the electrophysiologic J Cereh Blood Flow Metab, Vol. 19. No.9, 1999 assessment of epileptogenesis and in vitro or in vivo receptor binding. It has been shown that removal of the most frequently spiking areas defined either by scalp recorded interictal EEG or by intraoperative ECoG re sults in a good postoperative outcome in most cases (Sammaritano et aI., 1987; McBride et aI., 1991) . Thus, although the sensitivity and specificity of ECoG is infe rior to invasive ictal EEG for defining the epileptogenic region, ECoG was shown to be feasible for the differen tiation between epileptogenic and nonepileptogenic cor tex.
Consistent with previous studies (Sherwin et aI., 1986 , Olsen et aI., 1992 , there was no significant difference between the mean Ko of the epileptogenic neocortices and control tissue. This group comparison showed con siderable interindividual variation of the cortex affinity and thus was insensitive to possible changes in the Ko parameter. However, our paired comparison of spiking and nonspiking cortex from the same patients was more sensitive than previous studies that used nonspiking tis sue from different subjects. In the intrasubject compari son, differences arising from the preparation methods, different anatomical locations, underlying mechanisms of epilepsy, age, duration of epilepsy, seizure frequency, and medication are minimized. This approach of detect ing focal cortical binding abnormalities is also more comparable to the in vivo methods of analysis of FMZ binding where abnormal binding is based on the com parison of surrounding and contralateral homotopic cor tical regions instead of using interindividual comparison.
Laminar distribution of FMZ binding
The spiking cortex showed a higher receptor density in the cortical layers V -VI in all patients compared to non spiking cortex. Cortical layer V contains neurons with appropriate membrane properties, intralaminar connec tions, neurotransmitter systems, and axonal outputs to generate highly synchronized activity (Gutnick et aI., 1982; Connors, 1984 Connors, , 1998 White et aI., 1994; Castro Alamancos et aI., 1996) . This layer initiates synchro nized bursting when GAB A-mediated inhibition is sup pressed (Chagnac-Amitai and Connors, 1989) . In addi tion, a localized selective loss of GABAergic innervation in layer V of motor cortex in alumina gel-induced model of focal epilepsy was reported in monkeys suggesting that this process can have a causal role in the develop ment of seizure activity (Ribak et aI., 1979; Houser et aI., 1986) . Thus, the present finding of increased Bmax in layers V-VI suggests there may be impaired GABAergic innervation (Spreafico et aI., 1998) resulting in a com pensatory increase of BZD-R in the human epileptogenic neocortex.
In addition to the increase of BDZ-R in the layers V-VI (Fig. 5B to 5D ), there was a significant increase in Bmax for all layers of spiking neocortex compared to the nonspiking cortex (Figs. 3A and 5D ). This finding is consistent with in vitro data from animal models of par tial epilepsy (Ross and Craig, 1981; Booker et aI., 1986; Craig and Colasanti, 1986; Ben Attia et aI., 1992) as well as from human neocortex (Burdette et aI., 1995) showing increased Bmax in epileptic foci. This finding, however, was only statistically significant in the cortical layers V-VI (Burdette et aI., 1995) . It was suggested previously by several investigators that the increase of GABA A re ceptor density in the epileptic focus might be the result of postsynaptic receptor upregulation due to denervation (Ross and Craig, 1981; Ben Attia, 1992) . This could be a primary decrease of cortical GABA level, as suggested in studies showing a reduction of GAD activity of the epileptic cortex (Ribak et aI., 1979 (Ribak et aI., ,1989 Houser et aI., 1986; Esclapez et aI., 1989) . This notion is supported further by the finding of increased Bmax and simulta neous decreased GAD activity in epileptic cortex of co balt induced focal epilepsy in rat (Craig and Colasanti, 1986) .
Possible mechanism of a decreased in vivo FMZ binding
The finding of higher Bmax values in epileptogenic cortex compared to nonspiking appears to be a paradoxi cal finding because in vivo FMZ binding studies show a decrease in the epileptic focus (Savic et aI., 1988) . One would expect that a higher Bmax would result in higher FMZ binding in vivo. However, we have shown that there is a significant correlation between the Bmax and Ko values (Fig 4A) , while there is no such correlation in nonspiking tissue (data not shown). Furthermore, exami nation of the slope of the regression line reveals that for a onefold higher Bmax value, the Ko is approximately twofold higher. In other words, higher Bmax values in spiking tissue are associated with greater decreases in the affinity of FMZ for the receptor. Therefore, the observed decrease of in vivo FMZ binding may result from re duced affinity of FMZ for the receptor. This would sug gest that the affinity of FMZ for the receptor, rather than the number of binding sites in the tissue, is the deter mining factor causing decreased FMZ binding in the epi leptogenic cortex observed with PET in vivo.
In addition, our in vitro results are in contrast with PET findings of decreased in vivo Bmax in epileptogenic regions (Savic et aI., 1988 (Savic et aI., ,1998 . However, several dif ferences between the in vitro and in vivo approach of Bmax and Ko estimation must be considered when com paring these findings. Using PET imaging, Bmax and Ko values are estimated from Scatchard analysis using only two points. Because of the paucity of the data, the stan dard deviation of both parameters, especially that of Ko, increases. Very large coefficients of variation for Ko were reported, indicating the limited reliability of esti mation of Ko (Abadie et aI., 1992) . Furthermore, based on some previous in vivo studies (Savic et aI., 1988; Delforge et aI., 1995) , it was assumed that Ko is a con stant parameter in epilepsy, and the observed binding alteration is the consequence of the altered receptor den sity.
The correlation between the Ko and Bmax of the epi leptic cortex in our study indicates that these parameters are not independent. A similar correlation was previously found between in vivo measured Bmax and Ko in normal cortex (Millet et aI., 1995; Delforge et aI., 1995) , but no in vitro correlation has been reported. Although the cause of this correlation in normal conditions is uncertain, in epileptic cortex the increased Bmax can be considered as a result of a compensatory mechanism induced by de creased GAB A-mediated inhibition (e.g., due to de creased affinity). The value of the regression coefficient for this correlation suggests that this compensation is disproportionate with the affinity decrease. Thus, it can be concluded from our in vitro findings that decreased receptor affinity is an alteration that can lead to reduced BZD-R binding in vivo even when a compensatory Bmax increase occurs. The correlation between in vitro KD of the spiking cortex and the degree of decreased in vivo FMZ binding of the corresponding spiking area com pared to the contralateral homotopic region supports this assumption. Considering the multifactorial nature of epi leptogenesis, several other, still unknown factors are likely to contribute to altered GABA A -BDZ-R function (McDonald et aI., 1991) . Furthermore, the positive cor relation between the duration of the epilepsy and the KD values suggests that repeated seizures can be associated with a progressive decrease of receptor affinity.
Our findings suggest that the observed changes in BZD-R binding in epileptogenic neocortex cannot be ex plained simply by cell loss (Babb et aI., 1984 a; or by other histopathologic changes because alterations of binding parameters and receptor redistribution occurred with the same frequency in epileptic cortices with normal as well as \\\ ith abnormal histology. Therefore, functional receptor changes can occur even without apparent mor phologic alteration of the cerebral cortex. This is sup ported by recent in vivo BZD-R binding studies showing the occasional reversibility of altered BZD-R binding after either drug treatment (Staedt et aI., 1995) or epi lepsy surgery (Savic et aI., 1998) .
